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Abstract 
Background: Increased interleukin-17 (IL-17) leads to the production of proinflammatory mediators and 
increases local inflammation. Interleukin-17 may also promote receptor activator of nuclear factor kappa-
B ligand (RANKL) expression on gingival fibroblasts, T cells, and B cells, resulting in alveolar bone 
resorption. Interleukin-17A and IL-17F levels in saliva and gingival crevicular fluid (GCF), were found to 
be elevated in periodontitis patients. Thus, IL-17A and IL-17F polymorphisms were hypothesized to be 
associated with a risk of periodontitis. Methods: The present study was conducted on 60 subjects, including 
20 stage II grade B periodontitis patients, 20 stage III grade C periodontitis patients, and 20 healthy 
controls. Blood samples were drawn from the subjects and analyzed for IL-17A G-197A and IL-17F 
7488T/C genetic polymorphisms using the TaqMan assay. Results: There was a significant statistical 
difference between the distribution of the different genotypes and the different alleles in the three groups 
for IL-17A G-197A with the A allele presence indicating a risk of periodontitis. Conclusions: Interleukin-
17A G-197A polymorphism is significantly associated with different clinical forms of periodontitis in the 
Egyptian population. The A allele could be considered a risk factor for periodontal diseases. 
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Introduction 
Periodontitis, one of the major causes of tooth loss, 
is an inflammatory disease affecting the integrity 
of tooth-supporting tissues. Although periodontal 
diseases are caused by bacteria present in 
periodontal sites, the host response plays a 
decisive role in the breakdown of the connective 
tissue and bone. The host response is influenced 
by different risk factors with the genetic factor 
being one of them.1  
According to the proceedings from the 
2017 World Workshop on the Classification of 
Periodontal and Peri-Implant Diseases and 
Conditions, periodontitis is classified according to 
severity into four stages (I, II, III, and IV) and 
according to rate of progression into three 
grades (A, B, and C).2 Periodontitis severity or 
even appearance might be regulated by the 
genetic control of cytokine function. Gene 
polymorphisms of cytokines in different types of 
periodontitis have been investigated by several 
studies.3-5 
Interleukin-17 (IL-17) is a cytokine with a 
family of six different molecules (IL-17A, IL-17B, 
IL-17C, IL-17D, IL-17E and IL-17F), with IL-17A 
and IL-17F being the well-recognized 
inflammatory mediators.6 Interleukin-17 has 
different biological activities on several cells, such 
as fibroblasts, endothelial cells, and epithelial 
cells, with a stimulator effect on osteoclastic bone 
resorption by inducing receptor activator of 
nuclear factor kappa-B ligand (RANKL) 
expression on osteoblasts and stimulating the 
differentiation and activation of osteoclasts.7,8 
Interleukin-17 was found to control immune 
response activation so participating in the 
inflammatory response of the gingival tissue in 
periodontitis patients.9 Many studies have 
demonstrated the presence of IL-17 in 
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periodontal tissues, gingival crevicular fluid 
(GCF), saliva, and plasma of patients with 
periodontal disease.10-14 
Recently, the search for genetic markers 
linked to periodontal disease severity and 
susceptibility has been receiving significant 
attention. Gene polymorphisms encoding host 
defense system molecules have been specifically 
targeted as possible genetic markers. Variation 
in an allele of a certain gene can cause different 
phenotypic presentations affecting molecule 
production.15 
Interleukin-17A polymorphisms were 
found to partially influence red complex bacteria 
in periodontitis (formerly known as chronic 
periodontitis) patients by increasing the risk of 
Tannerella forsythia and Prevotella intermedia 
occurrence in sub-gingival pockets.16 IL-17F has a 
regulatory role in the immune response initiated 
by T-cells.17 
In a recent meta-analysis, high levels of IL-
17A and IL-17F were associated with rheumatoid 
arthritis suggesting a role of these cytokines in 
inflammatory disease. In addition, a significant 
association between IL-17F polymorphisms and 
the disease was found. This suggests that 
polymorphisms in these genes may affect 
periodontal disease progression.18 IL-17A and IL-
17F genes are mapped on the same chromosome 
at position 6p12, and the polymorphisms of IL-
17A G-197A and IL-17F 7488T/C have been 
associated with higher susceptibility to ulcerative 
colitis in addition to rheumatoid arthritis.19-21 
Aiming to assess the risk, prevention, and 
treatment of periodontitis, determination of gene 
allelic variants is of great interest in periodontal 
research. Polymorphisms in cytokine genes may 
lead to an altered phenotype, and to different 
cytokine responses among individuals due to 
different phenotype presentations. This will affect 
the individual’s susceptibility to disease as well as 
its progression and response to treatment.7 
Thus, we hypothesized that IL-17A G-
197A and IL-17F 7488T/C polymorphisms may 
be a risk factor for periodontitis. The aim of this 
pilot study was to detect IL-17A G-197A and IL-
17F 7488T/C polymorphisms in stage II grade B 
and stage III grade C periodontitis patients within 
the Egyptian population and to analyze their 
relation to the disease. 
Materials and Methods  
The study was conducted on 60 subjects, including 
20 stage II grade B periodontitis patients (group 
I), 20 stage III grade C periodontitis patients 
(group II), and 20 healthy controls (group III). The 
protocol was approved by the Research Ethics 
Committee of the Faculty of Oral and Dental 
Medicine, Cairo University, and the methods were 
carried out in accordance with the committee’s 
relevant guidelines and regulations. Informed 
consent was obtained from participants prior to 
inclusion in the study. Complete records of the 
periodontal examination, diagnosis, treatment, 
and recommended follow-up were maintained. 
All study participants were from the Egyptian 
population. Systemic diseases that correlate with 
periodontal disease such as polymorphonuclear 
leukocyte (PMN) and monocyte defects, HIV 
infection, or diabetes mellitus were excluded from 
the present study. Individuals with a history of 
antimicrobial therapy, periodontal surgery, or 
smoking within the 6 months prior to initiation of 
the study, and pregnant and lactating females 
were also excluded. 
Inclusion criteria for group I and II patients 
as well as patient grouping was in accordance 
with the clinical and radiographic criteria 
described in the 2017 World Workshop on the 
Classification of Periodontal and Peri-Implant 
Diseases and Conditions.2  
The patients’ periodontal condition was 
assessed in all groups. It included the following: 
plaque index (0-3, in accordance with Silness and 
Löe), gingival index (0-3, in accordance with Löe 
and Silness), periodontal probing depth (in 
accordance with Caton et al.), and clinical 
attachment level (in accordance with Glavind and 
Löe).22-25 Radiographic examination was used to 
aid the diagnosis. 
I. Blood Sample Collection 
Three milliliters of blood were collected from each 
subject in ethylenediaminetetraacetic acid (EDTA) 
tubes using venipuncture at the antecubital fossa. 
The tubes were maintained in ice and transported 
to the biochemistry lab at the Faculty of Medicine, 
Cairo University, where they were stored at -
70°C until all samples were collected. All 
collected samples were given a specific serial 
number and patient information was not shown on 
the sample labels. 
II. Genotyping of IL-17A and IL-17F   
DNA was isolated from the whole blood using a 
DNA extraction kit. Genotyping of single 
nucleotide polymorphisms (SNPs) in IL-17A G-
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197A (rs2275913) and IL-17F 7488T/C 
(rs763780) was based on polymerase chain 
reaction (PCR) using TaqMan assays.a Reaction 
mixture and conditions were designed according 
to the manufacturer’s instructions and fluorescence 
was measured using the rotor gene apparatus. 
III. Statistical Analysis 
Sample size was calculated using a power 
analysis that was based upon the results of Cheng 
et al.25 The effect size was found to be 0.82, using 
an alpha (α) level of 0.05 (5%), and a beta (β) 
level of 0.20 (20%) i.e. power = 80%. The 
minimum estimated sample size was 18 subjects 
per group, for a total of 54 subjects. The sample 
size was increased to 20 subjects per group to 
compensate for the use of non-parametric tests. 
Sample size was calculated using the G*Power 
computer software (version 3.1.9.2). 
Numerical data were explored for 
normality by checking the distribution of data and 
using tests of normality (Kolmogorov-Smirnov and 
Shapiro-Wilk tests). Age data showed normal 
(parametric) distribution while data for clinical 
parameters showed non-normal (non-parametric) 
distribution. Data were presented as mean and 
standard deviation (SD) values. 
For parametric data, the one-way 
analysis of variance (ANOVA) test was used to 
compare between the mean age values in the 
three groups. Tukey’s post-hoc test was used for 
pair-wise comparisons when ANOVA was 
significant. For non-parametric data, the Mann-
Whitney U test was used to compare between the 
clinical parameters of the different groups. The 
Kruskal-Wallis test was used to compare between 
clinical parameters among different genotypes. 
Dunn’s test was used for pair-wise comparisons 
when the Kruskal-Wallis test was significant. 
Qualitative data were presented as 
frequencies and percentages. Chi-square test (or 
Fisher’s exact test when applicable) was used for 
comparison of qualitative data. Odds ratios (ORs) 
with 95% confidence intervals (CIs) were used to 
study the association between genotypes and 
periodontitis. Confidence intervals for the odds 
ratios that included a “1” indicated a non-
statistically significant association between the 
studied variables. 
The Hardy-Weinberg equilibrium was 
calculated using the Court-Lab – HW calculator. 
The significance level was set at P ≤ 0.05. 
Statistical analysis was performed using IBM SPSS 
Statistics Version 20 for Windows. 
Results 
I. Demographic Data 
The stage II periodontitis group showed the 
highest mean age which was of statistical 
significance. The control group showed a 
significantly lower mean age, and the stage III 
periodontitis group showed the lowest mean age 
which was of statistical significance. 
There was no statistically significant 
difference regarding gender distribution in the 
three groups (Table 1).
 
 
Table 1. Descriptive statistics and results of one-way ANOVA and Chi-square tests for comparison 
between demographic data in the three groups 
 
Demographics 
Stage II Grade B 
Periodontitis 
(N=20) 
Stage III Grade C 
Periodontitis 
(N=20) 
Control 
(N=20) 
P Value 
Age (Mean ± SD) 45.4 ± 8.5 A 24.9 ± 5.6 C 31 ± 4.5 B <0.001* 
Female Gender [N(%)] 10/20 (50%) 11/20 (55%) 
11/20 
(55%) 
0.935 
Male Gender [N(%)] 10/20 (50%) 9/20 (45%) 
9/20 
(45%) 
 
*Significant at P≤0.05; different superscripts in the same row indicate statistically significant differences 
according to Tukey’s test. 
 
                                                          
a Thermo Fisher Scientific, Waltham, MA, USA 
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II. Genotype Data 
 
A. Comparison Between the Three Groups 
 
As regards to gene rs2275913, the AA 
genotype was found in 10 cases (50%) of group 
I, 10 cases (50%) of group II, and 5 cases (25%) 
of the control group. The AG genotype was found 
in 6 cases (30%) of group I, 6 cases (30%) of 
group II, and 2 cases (10%) of the control group. 
The GG genotype was found in 4 cases (20%) of 
group I, 4 cases (20%) of group II, and 13 cases 
(65%) of the control group (Table 2). There was 
a statistically significant difference between the 
three groups; the periodontitis groups (I and II) 
showed the highest prevalence of the AA and AG 
genotypes, while the control group showed the 
highest prevalence of the GG genotype. 
 
As for gene rs763780, the CC genotype 
was found in 6 cases (30%) of group I, 2 cases 
(10%) of group II, and 5 cases (25%) of the 
control group. The CT genotype was found in 6 
cases (30%) of group I, 7 cases (35%) of group 
II, and 3 cases (15%) of the control group. The TT 
genotype was found in 8 cases (40%) of group I, 
11 cases (55%) of group II, and 12 cases (60%) 
of the control group. There was no statistically 
significant difference between the three groups. 
 
B. Comparison Between Stage II 
Periodontitis and Control Group 
 
As regards to gene rs2275913, there was 
no statistically significant difference between the 
prevalence of the AA and AG genotypes in group 
I and the control group. As for the GG genotype, 
group I had a significantly lower prevalence of 
GG than the control group. The odds ratio was 
0.135. 
As for gene rs763780, there was no 
statistically significant difference between the 
prevalence of CC, CT, and TT genotypes in the 
group I and control groups (Table 3).
Table 2. The frequencies (N), percentages (%), and results of Fisher’s exact test comparing between 
genotype distributions in the three groups 
*Significant at P≤0.05 
 
Table 3. The frequencies, percentages, and results of Chi-square test comparing between genotype 
distribution in stage II grade B periodontitis and control group 
 
Genotype Gene 
Stage II Grade B 
Periodontitis 
(N=20) 
Control 
(N=20) 
P 
Value 
Odds 
Ratio 
95% CI 
  N % N %    
rs2275913 AA 10 50 5 25 0.102 3.000 
0.786 – 
11.445 
 AG 6 30 2 10 0.114 3.857 
0.673 – 
22.109 
 GG 4 20 13 65 0.004* 0.135 0.032 – 0.562 
rs763780 CC 6 30 5 25 0.723 1.286 0.319 – 5.175 
 CT 6 30 3 15 0.256 2.429 
0.512 – 
11.511 
 TT 8 40 12 60 0.206 0.444 0.125 – 1.575 
*Significant at P≤0.05
Genotype Gene 
Stage II Grade B 
Periodontitis 
(N=20) 
Stage III Grade C 
Periodontitis 
(N=20) 
Control 
(N=20) 
P Value 
  N % N % N %  
rs2275913 AA 10 50 11 55 5 25 
0.008*  AG 6 30 6 30 2 10 
 GG 4 20 3 15 13 65 
rs763780 CC 6 30 2 10 5 25 
0.330  CT 6 30 7 35 3 15 
 TT 8 40 11 55 12 60 
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C. Comparison Between Stage III 
Periodontitis and Control Groups 
As regards to gene rs2275913, there 
was no statistically significant difference 
between the prevalence of the AA and AG 
genotypes in group II and the control group, 
while the control group had a significantly 
higher prevalence of the GG genotype 
compared to group II. The odds ratio was 
0.095. 
As for gene rs763780, there was no 
statistically significant difference between 
the prevalence of the CC, CT, and TT 
genotypes in group II and the control group 
(Table 4). 
D. Hardy-Weinberg Equilibrium 
The observed genotypes of groups I and 
II were consistent with the Hardy-Weinberg 
equilibrium because the calculations were 
non-statistically significant. Genotypes of the 
control group however, were not consistent 
with Hardy-Weinberg equilibrium (Table 5). 
 
 
 Table 4. The frequencies, percentages, and results of Chi-square test comparing between genotype 
distribution in stage III grade C periodontitis and control group 
*Significant at P≤0.05 
 
Table 5. Hardy-Weinberg equilibrium calculations 
Genotype Stage II Grade B Periodontitis 
(N=20) 
Stage III Grade C Periodontitis 
(N=20) 
Control 
(N=20) 
rs2275913 x2 = 2.321 
P Value = 0.128 
x2 = 1.633 
P Value = 0.201 
x2 = 11.610 
P Value = 0.001* 
rs763780 x2 = 3.104 
P Value = 0.078 
x2 = 0.299 
P Value = 0.585 
x2 = 8.662 
P Value = 0.003* 
*Significant at P≤0.05 
 
Discussion  
Although bacteria present in periodontal 
sites are the main cause of periodontal 
diseases, the host response also plays a 
decisive role in connective tissue and bone 
breakdown. Genetic factors are involved in 
the pathogenesis of periodontitis playing an 
important role in the initiation of the host 
immune response, and variations in genes 
associated with immunoregulatory molecules 
are considered crucial.27,28 
Interleukin-17 is a proinflammatory 
cytokine with gene polymorphisms that are 
associated with a risk of development of 
periodontitis. Infiltration of IL-17 producing 
cells was found to be related to the severity 
of inflammation in periodontal disease.26 
Several studies have aimed to evaluate the 
association between the rs2275913 
polymorphism in IL-17A and the rs763780 
polymorphism in Il-17F with stage II grade 
B and stage III grade C periodontitis in 
different populations.16,29,30 
Genotype Gene 
Stage III Grade C 
Periodontitis 
(N=20) 
Control 
(N=20) 
P 
Value 
Odds 
Ratio 
95% CI 
  N % N %    
rs2275913 AA 11 55 5 25 0.053 3.667 
0.958 – 
14.028 
 AG 6 30 2 10 0.114 3.857 
0.673 – 
22.109 
 GG 3 15 13 65 0.001* 0.095 0.021 – 0.440 
rs763780 CC 2 10 5 25 0.212 0.333 0.056 – 1.971 
 CT 7 35 3 15 0.144 3.051 
0.659 – 
14.137 
 TT 11 55 12 60 0.749 0.815 0.232 – 2.860 
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In the present study we evaluated 
the rs2275913 polymorphism in IL-17A (G-
197A) and the rs763780 polymorphism in 
IL-17F (7488T/C) in 3 groups: stage II 
grade B periodontitis, stage III grade C 
periodontitis, and a control group. 
Regarding gene rs2275913 (G-197A), our 
results showed a significantly higher 
prevalence of the AA and AG genotypes in 
the periodontitis groups compared to the 
control, while the control group showed the 
highest prevalence of the GG genotype 
indicating that the presence of the A allele 
could be considered a risk factor for 
periodontitis in the Egyptian population. The 
stage II grade B periodontitis group had a 
lower prevalence of the GG genotype 
compared to the control group, which was 
of statistical significance. The odds ratio 
was 0.135 indicating that the GG 
genotype may be protective against stage 
II grade B periodontitis. This was in 
accordance with Corrêa et al. who studied 
IL-17A polymorphisms in chronic 
periodontitis. They stated that “the 
polymorphism of IL-17A, especially the SNP 
involving the allele A are associated with 
the clinical and inflammatory parameters of 
the disease” with evidence of increased 
levels IL-17A in serum as well as IL-8 and 
myeloperoxidase activity in gingival 
tissues.29 
The stage II grade C periodontitis 
group had a significantly lower prevalence 
of GG compared to the control group. The 
odds ratio was 0.095 indicating that the 
GG genotype may be protective against 
stage III grade C periodontitis. These results 
were consistent with Chaudhari et al., who 
found that the carriage of the AA genotype 
of IL-17A G-197A was significantly 
associated with the occurrence of both 
chronic periodontitis and localized 
aggressive periodontitis, and that the 
genotype GG was associated with a 
healthy periodontium.30 In contrast, a study 
done on the Brazilian population showed 
evidence that IL-17A expression and the A 
allele were found to be higher in healthy 
controls in comparison with the periodontitis 
groups.31 
Regarding gene rs763780, 
genotype and allele frequencies of IL-17F 
7488T/C polymorphisms were similar in 
both periodontitis groups and the healthy 
group with no statistically significant 
difference. There was no statistically 
significant difference between the 
prevalence of CC, CT, and TT genotypes in 
group II versus the control group nor 
between group I versus the control group. 
These finding were in agreement with 
Corrêa et al. and Valentini Zacarias et al., 
who stated that IL-17F polymorphisms were 
not associated with chronic periodontitis.7,29 
Saraiva et al. also found no association 
between IL-17F polymorphisms and 
different clinical presentations of 
periodontitis with the distribution of 
genotypes CT/TT and the alleles were 
similar between the periodontitis and the 
control groups suggesting a low frequency 
of polymorphic genotype of IL-17F.31 Thus, 
these results reinforce the idea that IL-17F 
has a weak proinflammatory role in the 
pathogenesis of periodontal diseases, 
although it has a high degree of similarity 
and shares many biological properties with 
IL-17A.32 
Several studies indicated that T 
helper 17 (Th17) cells (which predominantly 
secrete IL-17A and IL-17F) play a crucial 
role in the pathogenesis of autoimmune and 
inflammatory diseases such as rheumatoid 
arthritis, psoriasis, and inflammatory bowel 
diseases.33,34 IL-17 producing cells were 
also detected in high amounts in the 
gingival tissues of patients with periodontal 
disease especially in the apical portion of 
periodontal pockets where inflammation is 
higher, indicating a relation between IL-17 
and periodontal diseases.26 IL-17A 
promotes the expression of IL-8 through 
phosphorylation of nuclear factor kappa 
beta p65 subunit at serine 536-serine 
468.35 
In 2014 Azman et al. conducted a 
study to determine the clinical association 
between the IL-17 family and periodontitis 
in non-smoking systemically healthy 
patients. They concluded that the IL-17 
family has a role in periodontitis, with IL-
17A demonstrating a major 
proinflammatory action and influence on 
other IL-17 proinflammatory members, 
while IL-17E was suggested to cease 
inflammation through its anti-inflammatory 
action by particularly inhibiting 
prostaglandin.35 
In a study done by Corrêa et al. in 
2012, clinical parameters characteristic of 
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stage II grade B periodontitis were found to 
be associated with increased levels of IL-
17A and IL-17F in gingival tissues, while 
only IL-17A concentration was found to be 
high in serum.29 
In conclusion, the present study 
showed that IL-17A polymorphisms are 
significantly associated with different 
clinical forms of periodontitis in the 
Egyptian population. The A allele may be a 
risk factor for periodontal diseases and thus 
may be used as a diagnostic risk predictor 
for stage II and III periodontitis. Our main 
limitation was the small sample size for 
genetic study although a sample size 
calculation was considered as previously 
mentioned. 
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